TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction
Osaka Medical Center for Cancer and Cardiovascular Diseases · Japan Science and Technology Agency · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,201
total citations
- FWCI
- 35.39
- Percentile
- 100%
- References
- 45
Citations per year
Authors
5- HOHiroyuki OshiumiCorresponding
Osaka Medical Center for Cancer and Cardiovascular Diseases
- MMMisako Matsumoto
Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan Science and Technology Agency, Science and Technology Corporation (United States)
- KFKenji Funami
Osaka Medical Center for Cancer and Cardiovascular Diseases, Nara Institute of Science and Technology
- TATakashi Akazawa
Osaka Medical Center for Cancer and Cardiovascular Diseases
- TSTsukasa Seya
Japan Science and Technology Agency, Science and Technology Corporation (United States), Osaka Medical Center for Cancer and Cardiovascular Diseases, Nara Institute of Science and Technology
Topics & keywords
Topics
Keywords
- TLR3
- Signal transducing adaptor protein
- Toll-like receptor
- Cell biology
- Interferon
- TLR7
- TRIF
- Receptor
No related works found for this paper.